PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-33.30%
Negative revenue growth while 6617.T stands at 6.25%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-39.40%
Negative gross profit growth while 6617.T is at 7.27%. Joel Greenblatt would examine cost competitiveness or demand decline.
-3529.69%
Negative EBIT growth while 6617.T is at 108.87%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1904.15%
Negative operating income growth while 6617.T is at 144.07%. Joel Greenblatt would press for urgent turnaround measures.
-262.13%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-262.21%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-262.21%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.25%
Negative 10Y revenue/share CAGR while 6617.T stands at 15.88%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-28.34%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-14.36%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Negative 10Y OCF/share CAGR while 6617.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.57%
Negative 10Y net income/share CAGR while 6617.T is at 104.71%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-177.11%
Negative 5Y net income/share CAGR while 6617.T is 107.10%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-149.97%
Negative 3Y CAGR while 6617.T is 106.61%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
369.43%
10Y equity/share CAGR above 1.5x 6617.T's 2.70%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
47.76%
5Y equity/share CAGR above 1.5x 6617.T's 4.59%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
12.62%
3Y equity/share CAGR above 1.5x 6617.T's 1.31%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.86%
Our AR growth while 6617.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
13.08%
Inventory growth well above 6617.T's 3.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.98%
Positive asset growth while 6617.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-3.56%
We have a declining book value while 6617.T shows 0.15%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
19.32%
We have some new debt while 6617.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-2.35%
We cut SG&A while 6617.T invests at 3.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.